Viewing StudyNCT04580420



Ignite Creation Date: 2024-05-06 @ 3:18 PM
Last Modification Date: 2024-10-26 @ 1:46 PM
Study NCT ID: NCT04580420
Status: RECRUITING
Last Update Posted: 2024-07-11
First Post: 2020-09-24

Brief Title: Safety Efficacy of DCR-PHXC in Patients With PH12 and ESRD
Sponsor: Dicerna Pharmaceuticals Inc a Novo Nordisk company
Organization: Novo Nordisk AS

Conditions & Keywords Data

Conditions:
Name
End Stage Renal Disease
Primary Hyperoxaluria Type 1
Primary Hyperoxaluria Type 2
Keywords:
Name View
ESRD View
PH1 View
PH2 View